Did you know that every major advance in the fight against breast cancer has been touched by Susan G. Komen for the Cure®? That we've helped train more than 400 breast cancer researchers and funded more than 1,800 research projects over the past 26 years? That we've provided more money for breast cancer research and community health programs than any entity besides the U.S. government? Komen for the Cure's goal is to "energize science to find the cures."
Since 2008, Komen has been reshaping its Research Programs – from a complete redesign of the application and review process, to revised and enhanced science management of existing grants to a strategic shift in the focus of Komen research. Under the direction of Komen’s Chief Scientific Advisor, Dr Eric Winer, and Scientific Advisory Board Komen research emphasizes translational studies that will contribute to significant reductions in breast cancer mortality and/or incidence within the decade.
Among the important changes to our research process, is our transition to two annual announcements of Requests for Applications (RFA). Starting this year, Komen will consistently announce recurring research RFAs in April and May and will announce training RFAs in September. Announcements about additional special topic RFAs may be released at other times during the year.
Learn more about these grant opportunities
